8 000 shekels la boîte : le nouvel espoir pour les malades de schizophrénie hors de portée
Un médicament doté d'un nouveau mécanisme d'action offre une option thérapeutique supplémentaire aux personnes souffrant de la maladie, mais son prix laisse beaucoup de gens dans l'attente de son inclusion dans le panier de soins.…
Évaluation
A new schizophrenia drug with a novel mechanism of action has entered the Israeli market at 8,000 shekels per pack, placing it out of reach for most patients. The price tag means access depends entirely on inclusion in the national health basket, a bureaucratic process that moves slowly. One patient advocate states plainly that families simply cannot buy it if it stays outside the basket. The immediate question is whether the Health Ministry will prioritize this drug in the next basket update, and how many patients will wait in the meantime.